(Q41444542)

30 September 2017

1 reference

title

Hormone replacement therapy after breast cancer: a review (English)

1 reference

Hormone Replacement Therapy

30 September 2017

1 reference

Eden JA

1

1 reference

PubMed ID

9118119

30 September 2017

Wren BG

series ordinal

2

1 reference

30 September 2017

1 September 1996

1 reference

30 September 2017

Cancer Treatment Reviews

1 reference

30 September 2017

22

1 reference

30 September 2017

5

1 reference

30 September 2017

335-343

1 reference

The prevalence of menopausal symptoms in patients treated for breast cancer.

30 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Oral medroxyprogesterone in the treatment of postmenopausal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

A randomized double-blind cross-over trial into the effect of norethisterone on climacteric symptoms and biochemical profiles.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Strategies for prevention of osteoporosis and hip fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Estrogen replacement therapy in women with breast cancer: a survey of patient attitudes

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

G1 events and regulation of cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

The retinoblastoma protein and cell cycle control

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Inhibitors of mammalian G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Estrogens in plasma and fatty tissue from breast cancer patients and women undergoing surgery for non-oncological reasons

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Increased estrogen-16α-hydroxylase activity in women with breast and endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Cyclin D1 is a nuclear protein required for cell cycle progression in G1

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Endocrine management of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Oestrogen therapy after the menopause--boon or bane?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Menopausal Estrogen Replacement Therapy and Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Long-term surveillance of mortality and cancer incidence in women receiving hormone replacemen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Decreased mortality in users of estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Hormone replacement therapy and tumour grade in breast cancer: prospective study in screening unit

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Treatment of menopausal symptoms in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Hormone replacement therapy in previously treated breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Hormone-replacement therapy in patients with breast cancer. A reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Hormone replacement after breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

Estrogen replacement therapy withdrawal and regression of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2896%2990006-7

7 January 2021

10.1016/S0305-7372(96)90006-7

Identifiers

DOI

1 reference

30 September 2017

1 reference

PubMed ID

9118119